Journal
NPJ PARKINSONS DISEASE
Volume 7, Issue 1, Pages -Publisher
NATURE RESEARCH
DOI: 10.1038/s41531-020-00147-6
Keywords
-
Categories
Funding
- NCI Cancer Center Support Grant [5P30 CA023108-37]
- Michael J. Fox Foundation (MJFF)
- NIH/NIEHS [1R01ES024745, F31ES030982-01]
- NIH [U01NS082157, U01NS095736, U01NS100603, R01AG057331]
- MJFF
- American Parkinson Disease Association
- Harvard NeuroDiscovery Center, NINDS [U01NS082157, U01NS100603]
- Massachusetts Alzheimer's Disease Research Center [NIA P50AG005134]
Ask authors/readers for more resources
Parkinson's disease is a neurodegenerative disorder characterized by loss of dopaminergic neurons and research suggests that inflammation and cell death play a role in the disease. Monitoring and modifying these processes may improve disease management. Study findings indicate inflammasome activity in neurodegenerative disorders, with potential for diagnosing and monitoring inflammation in Parkinson's patients.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and loss of dopaminergic neurons of the substantia nigra. Inflammation and cell death are recognized aspects of PD suggesting that strategies to monitor and modify these processes may improve the management of the disease. Inflammasomes are pro-inflammatory intracellular pattern recognition complexes that couple these processes. The NLRP3 inflammasome responds to sterile triggers to initiate pro-inflammatory processes characterized by maturation of inflammatory cytokines, cytoplasmic membrane pore formation, vesicular shedding, and if unresolved, pyroptotic cell death. Histologic analysis of tissues from PD patients and individuals with nigral cell loss but no diagnosis of PD identified elevated expression of inflammasome-related proteins and activation-related speck formation in degenerating mesencephalic tissues compared with controls. Based on previous reports of circulating inflammasome proteins in patients suffering from heritable syndromes caused by hyper-activation of the NLRP3 inflammasome, we evaluated PD patient plasma for evidence of inflammasome activity. Multiple circulating inflammasome proteins were detected almost exclusively in extracellular vesicles indicative of ongoing inflammasome activation and pyroptosis. Analysis of plasma obtained from a multi-center cohort identified elevated plasma-borne NLRP3 associated with PD status. Our findings are consistent with others indicating inflammasome activity in neurodegenerative disorders. Findings suggest mesencephalic inflammasome protein expression as a histopathologic marker of early-stage nigral degeneration and suggest plasma-borne inflammasome-related proteins as a potentially useful class of biomarkers for patient stratification and the detection and monitoring of inflammation in PD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available